Intimation of Investor Presentation

Fabtech Technologies Ltd. presented its FY26 investor update, reporting a resilient year with strong financial performance. Standalone revenue grew 25.7% YoY to ₹410.77 Cr, and operational profit increased 17.0% YoY to ₹36.60 Cr. The company secured a consolidated order book of over ₹900 Cr as of March 31, 2026, providing significant revenue visibility. Strategic expansions include entry into Animal Health, KSA vaccine and pharma projects, large Africa pharma wins, and a European acquisition, positioning it as a global life sciences infrastructure platform.